Senestech Inc Stock Price, News & Analysis

SenesTech (NASDAQ: SNES), a leader in fertility control solutions for rodent population management, has announced its participation in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit. The company will engage in a virtual fireside chat on Tuesday, April 1, 2025, at 3:00 p.m. ET.

The event will be accessible through the conference website at lythampartners.com/ibmsummit25/ or directly via lythampartners.com/ibmsummit25/snes/. A replay option will be available through the same links. Additionally, interested parties can schedule one-on-one investor meetings following the event by reaching out to Lytham Partners representatives.

SenesTech (NASDAQ: SNES) reported strong Q4 2024 financial results, with revenue increasing 70% to $501,000 compared to Q4 2023. The company achieved a 60.9% gross profit margin, up from 43.7% in Q4 2023, while reducing operating expenses by 16%. Net loss decreased to $1.3 million from $1.7 million year-over-year.

The company's Evolve™ Rat product line contributed 52% of Q4 2024 revenue, while the newly launched Evolve™ Mouse accounted for 24%. E-commerce sales grew 206%, with successful launches on major platforms including Amazon and Walmart. The company has expanded internationally into 10 countries and secured municipal programs in several U.S. cities.

SenesTech announced new optimization initiatives expected to reduce expenses by $2 million annually, lowering the revenue threshold for cash flow breakeven from $12 million to approximately $7 million. The company's cash position stood at $1.3 million as of December 31, 2024, with an additional $2 million raised in Q1 2025 through ATM facility and warrant exercises.

SenesTech (NASDAQ: SNES) has announced warrant exercise agreements that will generate approximately $1.1 million in gross proceeds. The company, specializing in fertility control solutions for rodent populations, will allow the exercise of 374,718 outstanding warrants at a reduced price of $2.90 per share, down from the original $4.35.

As part of the transaction, SenesTech will issue new unregistered short-term warrants to purchase up to 1,498,872 shares at $2.90 per share, potentially generating an additional $4.3 million if fully exercised. These new warrants will be exercisable upon stockholder approval and expire 18 months thereafter. H.C. Wainwright is serving as the exclusive placement agent, with the transaction expected to close around March 11, 2025.

SenesTech (NASDAQ: SNES) has announced it will release its fourth quarter and fiscal year 2024 financial results on Wednesday, March 12, 2025, after market close. The company will host a conference call the same day at 5:00 pm ET to discuss the results.

Investors can join the conference call by dialing (844) 308-3351 or (412) 317-5407. A live webcast will be available through the company's Investor Relations website. A teleconference replay will be accessible for seven days using replay code 7759112, while the webcast replay will remain available for 90 days on the company's investor website.

SenesTech (NASDAQ: SNES) announces expansion into New Zealand and Australia markets with its Evolve™ rodent fertility control solution. The company expects regulatory approval in New Zealand by Q3 2025, with shipments beginning in late Q2 or early Q3. Through partnership with Evicom, SenesTech aims to integrate into New Zealand's Predator Free 2050 initiative, a $4.5 billion conservation program.

The expansion targets Australia's growing rodent pest control market, currently valued at $100 million and growing 5% annually. SenesTech projects regional annual demand for Evolve to reach or exceed $500,000. The product offers a non-lethal alternative to traditional rodenticides, addressing environmental concerns while maintaining effectiveness in pest management.

SenesTech (NASDAQ: SNES) has announced a significant expansion into the warehousing and distribution sector with a multi-pallet shipment of its Evolve™ Rodent Birth Control product to a major Midwest warehousing and distribution company. The unnamed customer plans to both implement the product in their facilities and distribute it through their network.

This strategic move targets the U.S. warehousing industry, which comprises over 18 billion square feet of industrial and logistics real estate. The company's non-lethal rodent control solution addresses unique challenges in food storage facilities where traditional poisons are often unsuitable due to safety concerns.

SenesTech (NASDAQ: SNES) has announced the expansion of its e-commerce presence by making its Evolve™ Rodent Birth Control product line available on TractorSupply.com. This strategic move adds to SenesTech's existing online retail presence on Amazon, Walmart.com, and DIYpestcontrol.com.

Tractor Supply Company, the largest rural lifestyle retailer in the United States with over 2,200 stores across 49 states, serves farmers, ranchers, homeowners, and outdoor enthusiasts. The company reported that its Amazon store has seen a 27% quarter-over-quarter increase in sales, demonstrating strong growth in the e-commerce segment.

SenesTech (SNES) has announced plans to enter the Indian rodent pest control market through a partnership with SMark, an India-based distributor. The companies have signed a letter of intent to introduce Evolve Rodent Birth Control™, a non-lethal pest control solution, to the Indian market.

The Indian rodent pest control market, valued at over $81 million and growing at 10% annually, presents significant opportunities driven by urbanization, agriculture demand, and public health concerns. The partnership leverages SMark's local expertise and distribution network to navigate regulatory and commercial complexities in India.

Evolve's approach focuses on controlling rodent populations by restricting reproduction, offering an eco-friendly alternative to traditional poisons that aligns with regulatory preferences for sustainable pest control solutions.

SenesTech (NASDAQ: SNES) announces that the City of Baltimore has integrated Evolve™, their rodent birth control product, into the city's pest management programs. Baltimore, recently ranked among America's 'rattiest cities', has placed a substantial initial order for deployment this quarter.

The initiative aims to address rodent overpopulation through a non-lethal approach that targets reproduction in both male and female rodents. Guy Bell, Chief of the Property Management Division at Baltimore City Department of Public Works, supports the strategy of preventing rat breeding. Joel Fruendt, SenesTech's CEO, emphasizes the product's role in addressing urban rodent challenges.

Evolve, designated as 'minimum risk' by the EPA, offers a sustainable alternative to traditional poisons and traps. The deployment will initially focus on high-impact areas to evaluate effectiveness in reducing rodent populations while ensuring environmental and public health safety.